Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis

To evaluate the prognostic effect of neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer (EOC) patients with different histological subtype. Stage III/IV EOC patients diagnosed between 2010 and 2018 were identified from the surveillance, epidemiology, and end results database (SEER...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuexi, Ni, Meng, Huang, Fanfan, Gu, Qiuying, Xiao, Yao, Du, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875958/
https://www.ncbi.nlm.nih.gov/pubmed/36705377
http://dx.doi.org/10.1097/MD.0000000000032774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875958/
https://www.ncbi.nlm.nih.gov/pubmed/36705377
http://dx.doi.org/10.1097/MD.0000000000032774

Ejemplares similares